Literature DB >> 2688102

Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis.

M Talbot1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688102     DOI: 10.1055/s-2007-1002722

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  8 in total

1.  Clotting for the Clinician: An Overview of Thrombosis and Antithrombotic Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Pharmacokinetics of rec-hirudin in healthy volunteers after intravenous administration.

Authors:  J M Cardot; G Y Lefèvre; J A Godbillon
Journal:  J Pharmacokinet Biopharm       Date:  1994-04

3.  Heparin in interventional radiology: a therapy in evolution.

Authors:  Stuart B Resnick; Stephanie H Resnick; Joshua L Weintraub; Nishita Kothary
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

4.  Direct Comparison of Aspirin Plus Hirudin, Aspirin Plus Heparin, and Aspirin Alone Among 12,000 Patients with Acute Myocardial Infarction Not Receiving Thrombolysis: Rationale and Design of the First American Study of Infarct Survival (ASIS-1).

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

5.  Hirudin in Acute Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

6.  Desirudin: a review of its use in the management of thrombotic disorders.

Authors:  A J Matheson; K L Goa
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

7.  Isolation and properties of two forms of thrombin inhibitor from the nymphs of the camel tick Hyalomma dromedarii (Acari: Ixodidae).

Authors:  M A Ibrahim; A H Ghazy; T Maharem; M Khalil
Journal:  Exp Appl Acarol       Date:  2001       Impact factor: 2.132

8.  Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction.

Authors:  Y Liu; R D Fields; B W Festoff; P G Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.